The power of data to accelerate drug discovery and reduce research costs offers new hope to patients. After the covid-19 was declared a pandemic, the commitment of life sciences companies to invest in Big Data and AI is confirmed by big pharma’s investment of billions of dollars into mining anonymized patient records to aid drug discovery has been on the high. These investments are being undertaken in the hope of expanding the patient universe which will benefit from existing medicines, while also discovering new drugs. How urgent is it for the whole world to embrace AI technology in data analytics ?

